Literature DB >> 33972639

Spatial heterogeneity of hepatic fibrosis in primary sclerosing cholangitis vs. viral hepatitis assessed by MR elastography.

Rolf Reiter1,2,3, Mehrgan Shahryari4, Heiko Tzschätzsch4, Dieter Klatt5, Britta Siegmund6, Bernd Hamm4, Jürgen Braun7, Ingolf Sack4, Patrick Asbach4.   

Abstract

Spatial heterogeneity of hepatic fibrosis in primary sclerosing cholangitis (PSC) in comparison to viral hepatitis was assessed as a potential new biomarker using MR elastography (MRE). In this proof-of-concept study, we hypothesized a rather increased heterogeneity in PSC and a rather homogeneous distribution in viral hepatitis. Forty-six consecutive subjects (PSC: n = 20, viral hepatitis: n = 26) were prospectively enrolled between July 2014 and April 2017. Subjects underwent multifrequency MRE (1.5 T) using drive frequencies of 35-60 Hz and generating shear-wave speed (SWS in m/s) maps as a surrogate of stiffness. The coefficient of variation (CV in %) was determined to quantify fibrosis heterogeneity. Mean SWS and CV were 1.70 m/s and 21% for PSC, and 1.84 m/s and 18% for viral hepatitis. Fibrosis heterogeneity was significantly increased for PSC (P = 0.04) while no difference was found for SWS of PSC and viral hepatitis (P = 0.17). Global hepatic stiffness was similar in PSC and viral hepatitis groups, but spatial heterogeneity may reveal spatial patterns of stiffness changes towards enhanced biophysics-based diagnosis by MRI.

Entities:  

Year:  2021        PMID: 33972639     DOI: 10.1038/s41598-021-89372-4

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  36 in total

1.  Correlation between quantitative liver and spleen volumes and disease severity in primary sclerosing cholangitis as determined by Mayo risk score.

Authors:  Pegah Khoshpouri; Sanaz Ameli; Mounes Aliyari Ghasabeh; Ankur Pandey; Manijeh Zarghampour; Farnaz Najmi Varzaneh; Angela Jacob; Pallavi Pandey; Yan Luo; Ihab R Kamel
Journal:  Eur J Radiol       Date:  2018-10-09       Impact factor: 3.528

Review 2.  Magnetic Resonance Imaging in Primary Sclerosing Cholangitis-Current State and Future Directions.

Authors:  Roman Zenouzi; Christopher L Welle; Sudhakar K Venkatesh; Christoph Schramm; John E Eaton
Journal:  Semin Liver Dis       Date:  2019-04-30       Impact factor: 6.115

3.  Radiologic course of primary sclerosing cholangitis: assessment by three-dimensional magnetic resonance cholangiography and predictive features of progression.

Authors:  Ana Ruiz; Sara Lemoinne; Fabrice Carrat; Christophe Corpechot; Olivier Chazouillères; Lionel Arrivé
Journal:  Hepatology       Date:  2013-11-22       Impact factor: 17.425

4.  MR imaging features of primary sclerosing cholangitis: patterns of cirrhosis in relationship to clinical severity of disease.

Authors:  Till R Bader; Kimberly L Beavers; Richard C Semelka
Journal:  Radiology       Date:  2003-03       Impact factor: 11.105

5.  Cross-sectional imaging in patients with primary sclerosing cholangitis: Single time-point liver or spleen volume is associated with survival.

Authors:  Pegah Khoshpouri; Maryam Ghadimi; Roya Rezvani Habibabadi; Mina Motaghi; Bharath Ambale Venkatesh; Mohammadreza Shaghaghi; Ankur Pandey; Bita Hazhirkarzar; Sanaz Ameli; Mounes Aliyari Ghasabeh; Pallavi Pandey; Ihab R Kamel
Journal:  Eur J Radiol       Date:  2020-10-04       Impact factor: 3.528

6.  Is there a role for liver biopsy in primary sclerosing cholangitis?

Authors:  Kelly W Burak; Paul Angulo; Keith D Lindor
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864

7.  Imaging Features of Primary Sclerosing Cholangitis: From Diagnosis to Liver Transplant Follow-up.

Authors:  Pegah Khoshpouri; Roya Rezvani Habibabadi; Bita Hazhirkarzar; Sanaz Ameli; Maryam Ghadimi; Mounes Aliyari Ghasabeh; Christine O Menias; Amy Kim; Zhiping Li; Ihab R Kamel
Journal:  Radiographics       Date:  2019-10-18       Impact factor: 5.333

8.  New LncRNAs in Chronic Hepatitis C progression: from fibrosis to hepatocellular carcinoma.

Authors:  Adriana Camargo Ferrasi; Geysson Javier Fernandez; Rejane Maria Tommasini Grotto; Giovanni Faria Silva; Joao Goncalves; Marina C Costa; Francisco J Enguita; Maria Inês de Moura Campos Pardini
Journal:  Sci Rep       Date:  2020-06-18       Impact factor: 4.379

9.  Plasma FABP4 is associated with liver disease recovery during treatment-induced clearance of chronic HCV infection.

Authors:  Jean-Baptiste Gorin; David F G Malone; Benedikt Strunz; Tony Carlsson; Soo Aleman; Niklas K Björkström; Karolin Falconer; Johan K Sandberg
Journal:  Sci Rep       Date:  2020-02-07       Impact factor: 4.379

10.  Incidence and risk factors of hepatocellular carcinoma in patients with hepatitis C in China and the United States.

Authors:  Ming Yang; Neehar D Parikh; Huixin Liu; Elizabeth Wu; Huiying Rao; Bo Feng; Andy Lin; Lai Wei; Anna S Lok
Journal:  Sci Rep       Date:  2020-12-01       Impact factor: 4.379

View more
  2 in total

Review 1.  MR elastography in primary sclerosing cholangitis: a pictorial review.

Authors:  Christopher L Welle; Patrick J Navin; Michael C Olson; Safa Hoodeshenas; Michael S Torbenson; Sudhakar K Venkatesh
Journal:  Abdom Radiol (NY)       Date:  2022-05-14

2.  Inhomogeneous liver fibrosis distribution revealed by macromolecular proton fraction quantification based on spin-lock MRI.

Authors:  Yurui Qian; Vincent Wai-Sun Wong; Jian Hou; Baiyan Jiang; Winnie Chiu-Wing Chu; Weitian Chen
Journal:  Quant Imaging Med Surg       Date:  2022-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.